SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Nov-23 9:15 PM View: | Korro Bio, Inc. (KRRO) | 03-Nov-23 | Grant | 35,114 | -- | -- | 100% 0 to 35.11K | |
09-Mar-23 9:12 AM View: | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition | 6,328 | $7.12 | $45,055.40 | (6%) 103.88K to 97.55K | |
09-Mar-23 9:12 AM View: | F-Star Therapeutics, Inc. (FSTX) | 08-Mar-23 | Disposition (change in control) | 97,547 | $7.12 | $694,535.00 | (100%) 97.55K to 0 | |
02-Feb-21 4:17 PM View: | F-Star Therapeutics, Inc. (FSTX) | 01-Feb-21 | Grant | 87,000 | -- | -- | 516% 16.88K to 103.88K | |
08-Dec-17 5:27 PM View: | Intellia Therapeutics, Inc. (NTLA) | 08-Dec-17 | Market Sale | 94,143 | $20.82 | $1,960,150.00 | (17%) 552.39K to 458.25K | (198%) |
08-Dec-17 5:27 PM View: | Intellia Therapeutics, Inc. (NTLA) | 07-Dec-17 | Market Sale | 131,140 | $21.14 | $2,771,870.00 | (19%) 683.53K to 552.39K | (193%) |
08-Dec-17 5:27 PM View: | Intellia Therapeutics, Inc. (NTLA) | 06-Dec-17 | Market Sale | 111,500 | $20.34 | $2,268,000.00 | (14%) 795.03K to 683.53K | (205%) |
05-Jun-17 7:53 AM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jun-17 | Grant | 8,400 | $11.95 | $100,379.00 | 1% 786.63K to 795.03K | 419% |
11-May-16 6:33 PM View: | Intellia Therapeutics, Inc. (NTLA) | 11-May-16 | Conversion | 437,019 | -- | -- | 125% 349.61K to 786.63K |